Abstract
Today’s psychopharmacological drugs remain focused on targets that were identified serendipitously more than half a century ago. As these targets have not proven to be at the core of the pathophysiology of the major psychiatric disorders, a better understanding of the disease biology seems a crucial step to identify more efficacious treatments. The tools to realize this goal include neuroendocrine, protein, transcription and genetic markers, neuroimaging and neurophysiological approaches. Obviously, the benefit for psychiatric patients of identifying a pattern of blood-based markers that combine information on the disease biology and treatment response would be enormous. Our transcription data from human blood cells suggest that this is a realistic possibility for the future. Ideally, markers identified in patients would be translated into distinct, hypothesis-driven animal models to facilitate conclusions on the potential therapeutic utility of novel compounds. The combined use of disease state and mechanistic models may characterize cellular and molecular mechanisms of various aspects of psychiatric disorders. This information, in turn, could help establish in vitro models that link cellular targets to (novel) pharmacological approaches. With the discussions around DSM-V, it can be hoped that ambitious research agenda will guide and stimulate systematic research into the biology and biological markers of psychiatric disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Akt:
-
Serine/threonine-specific protein kinase
- ANOVA:
-
Analysis of Variance
- Bcl-2:
-
B-cell leukemia/lymphoma 2
- BDNF:
-
Brain derived neurotrophic factor
- CMS:
-
Chronic mild stress
- CRF:
-
Corticotropin-releasing factor
- DISC-1:
-
Disrupted-in-schizophrenia 1
- DNA:
-
Deoxyribonucleic acid
- DSM:
-
Diagnostic and Statistical Manual
- DST:
-
Dexamethasone suppression test
- FST:
-
Forced swim test
- GR:
-
Glucocorticoid receptor
- HAB:
-
rats High anxiety bred rats
- HPA:
-
axis Hypothalamic–pituitary–adrenal axis
- 5-HT:
-
Serotonin
- HUPO:
-
Human Proteome Organization
- ICD:
-
International Classification of Diseases
- LAB:
-
rats Low anxiety bred rats
- LC:
-
Locus coeruleus
- LH:
-
Learned helplessness
- mGlu2/3:
-
Metabotropic glutamate 2/3 receptor
- MPfc:
-
Medial prefrontal cortex
- MR:
-
Mineralocorticoid receptor
- NCE:
-
New Chemical Entity
- NIMH:
-
National Institute of Mental Health
- NRG1:
-
Neuregulin-1
- PBMC:
-
Peripheral blood mononuclear cells
- Pelora:
-
Penalized logistic regression
- ProDaC:
-
Proteomics Data Collection
- Qpcr:
-
Quantitative Polymerase-chain reaction
- RNA:
-
Ribonucleic acid
- SGZ:
-
Subgranular zone
- SiRNA:
-
Small interfering ribonucleic acid
- SLR:
-
Stepwise logistic regression
- SVZ:
-
Subventricular zone
- TST:
-
Tail suspension test
- VEGF:
-
Vascular endothelial growth factor
References
A Research Agenda for DSM-V™. Washington, D.C. American Psychiatric Association (2002)
Abercrombie, E. D., Jacobs, B. L.: (1987)Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. I. Acutely presented stressful and nonstressful stimuli. J Neurosci 7, 2837–2843
Akaoka, H., Aston-Jones, G.: (1991)Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J Neurosci 11, 3830–3839
Alfonso, J., Pollevick, G. D., Hart, M. G., van der Flugge, G., Fuchs, E., Frasch, A. C.: (2004)Identification of genes regulated by chronic psychosocial stress and antidepressant treatment in the hippocampus. Eur J Neurosci 19, 659–666
Altar, C. A., Laeng, P., Jurata, L. W., Brockman, J. A., Lemire, A., Bullard, J., Bukhman, Y. V., Young, T. A., Charles, V., Palfreyman, M. G.: (2004)Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 24, 2667–2677
Andersen, C. L., Jensen, J. L., Orntoft, T. F.: (2004)Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64, 5245–5250
Armitage, R., Hoffmann, R. F., Rush, A. J.: (1999)Biological rhythm disturbance in depression: temporal coherence of ultradian sleep EEG rhythms. Psychol. Med. 29, 1435–1448
Armitage, R., Hoffmann, R., Trivedi, M., Rush, A. J.: (2000)Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. Psychiatry Res. 95, 201–213
Armitage, R., Emslie, G. J., Hoffmann, R. F., Rintelmann, J., Rush, A. J.: (2001)Delta sleep EEG in depressed adolescent females and healthy controls. J. Affect. Disord. 63, 139–148
Armitage, R., Hoffmann, R., Emslie, G., Rintelmann, J., Robert, J.: (2006)Sleep microarchitecture in childhood and adolescent depression: temporal coherence. Clin. EEG. Neurosci. 37, 1–9
Atz, M., Walsh, D., Cartagena, P., Li, J., Evans, S., Choudary, P., Overman, K., Stein, R., Tomita, H., Potkin, S., Myers, R., Watson, S. J., Jones, E. G., Akil, H., Bunney, W. E., Jr.Vawter, M. P.: (2007)Methodological considerations for gene expression profiling of human brain. J. Neurosci. Methods 163, 295–309
Avissar, S., Matuzany-Ruban, A., Tzukert, K., Schreiber, G.: (2004)Beta-arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain. Am. J. Psychiatry 161, 2066–2072
Basta-Kaim, A., Budziszewska, B., Jaworska-Feil, L., Tetich, M., Kubera, M., Leskiewicz, M., Lason, W.: (2005)Inhibitory effect of imipramine on the human corticotropin-releasing-hormone gene promoter activity operates through a PI3-K/AKT mediated pathway. Neuropharmacology 49, 156–164
Bellon, A.: (2007)New genes associated with schizophrenia in neurite formation: a review of cell culture experiments. Mol Psychiatry 12, 620–629
Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69, 89–95 (2001)
Birthelmer, A., Ehret, A., Riegert, C., Rothmaier, A. K., Leemhuis, J., Jackisch, R.: (2007)Modulation of electrically evoked serotonin release in cultured rat raphe neurons. J Neurochem 100, 1613–1625
Blackwood, D. H., Pickard, B. J., Thomson, P. A., Evans, K. L., Porteous, D. J., Muir, W. J.: (2007)Are some genetic risk factors common to schizophrenia, bipolar disorder and depression? Evidence from DISC1, GRIK4 and NRG1. Neurotox. Res 11, 73–83
Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., Maes, M.: (2002)Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J. Clin. Psychopharmacol. 22, 86–90
Borsini, F.: (1995)Role of the serotonergic system in the forced swimming test. Neurosci Biobehav. Rev 19, 377–395
Bosotti, R., Locatelli, G., Healy, S., Scacheri, E., Sartori, L., Mercurio, C., Calogero, R., Isacchi, A.: (2007)Cross platform microarray analysis for robust identification of differentially expressed genes. BMC Bioinformatics 8 Suppl 1, S5
Brazeau, D. A.: (2004)Combining genome-wide and targeted gene expression profiling in drug discovery: microarrays and real-time PCR. Drug Discov. Today. 9, 838–845
Bremner, J. D., Krystal, J. H., Southwick, S. M., Charney, D. S.: (1996)Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse. 23, 28–38
Brenner, S., Johnson, M., Bridgham, J., Golda, G., Lloyd, D. H., Johnson, D., Luo, S., McCurdy, S., Foy, M., Ewan, M., Roth, R., George, D., Eletr, S., Albrecht, G., Vermaas, E., Williams, S. R., Moon, K., Burcham, T., Pallas, M., DuBridge, R. B., Kirchner, J., Fearon, K., Mao, J., Corcoran, K.: (2000)Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays. Nat. Biotechnol. 18, 630–634
Browning, M. D., Dudek, E. M., Rapier, J. L., Leonard, S., Freedman, R.: (1993)Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 34, 529–535
Budziszewska, B., Jaworska-Feil, L., Tetich, M., Basta-Kaim, A., Kubera, M., Leskiewicz, M., Lason, W.: (2004)Regulation of the human corticotropin-releasing-hormone gene promoter activity by antidepressant drugs in Neuro-2A and AtT-20 cells. Neuropsychopharmacology 29, 785–794
Bundey, R. A., Iredale, P. A., Kendall, D. A.: (1997)Corticosteroid modulation of signal transduction in the CATH.a cell line. J Neurochem 68, 362–369
Bundey, R. A., Kendall, D. A.: (1999)Inhibition of receptor-mediated calcium responses by corticotrophin-releasing hormone in the CATH.a cell line. Neuropharmacology 38, 39–47
Canales, R. D., Luo, Y., Willey, J. C., Austermiller, B., Barbacioru, C. C., Boysen, C., Hunkapiller, K., Jensen, R. V., Knight, C. R., Lee, K. Y., Ma, Y., Maqsodi, B., Papallo, A., Peters, E. H., Poulter, K., Ruppel, P. L., Samaha, R. R., Shi, L., Yang, W., Zhang, L., Goodsaid, F. M.: (2006)Evaluation of DNA microarray results with quantitative gene expression platforms. Nat. Biotechnol. 24, 1115–1122
Capuron, L., Dantzer, R.: (2003)Cytokines and depression: the need for a new paradigm. Brain Behav. Immun. 17 Suppl 1, S119–S124
Capuron, L., Miller, A. H.: (2004)Cytokines and psychopathology: lessons from interferon-alpha. Biol. Psychiatry 56, 819–824
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., Miller, A. H.: (2003a)Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol. Psychiatry 54, 906–914
Capuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Miller, A. H.: (2003b)Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am. J. Psychiatry 160, 1342–1345
Carroll, B. J., Curtis, G. C., Mendels, J.: (1976)Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch. Gen. Psychiatry 33, 1051–1058
Carroll, B. J., Cassidy, F., Naftolowitz, D., Tatham, N. E., Wilson, W. H., Iranmesh, A., Liu, P. Y., Veldhuis, J. D.: (2007)Pathophysiology of hypercortisolism in depression. Acta Psychiatrica Scandinavica 115, 90–103
Cartmell, J., Schoepp, D. D.: (2000)Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75, 889–907
Charmandari, E., Tsigos, C., Chrousos, G.: (2005)Endocrinology of the stress response. Annu. Rev Physiol 67, 259–284
Charney, D. S., Heninger, G. R., Breier, A.: (1984)Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch. Gen. Psychiatry 41, 751–763
**Charney DS, Barlow DH, Botteron K, Cohen JD, Goldman D, Gur RE, Lin K-M, Lopez JF, Meador-Woodruff JH, Moldin SO, Nestler EJ, Watson SJ, Zalcman SJ. 2002. Neuroscience Research Agenda to Guide Development of a Pathophysiologically Based Classification System. In: Kupfer DJ, First MB, Regier DA, A Research Agenda for DSM-V™ American Psychiatric Association, Washington, D.C.:p. 31–84.
Chiou, S. H., Chen, S. J., Peng, C. H., Chang, Y. L., Ku, H. H., Hsu, W. M., Ho, L. L., Lee, C. H.: (2006a)Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell. Biochem Biophys. Res Commun. 343, 391–400
Chiou, S. H., Ku, H. H., Tsai, T. H., Lin, H. L., Chen, L. H., Chien, C. S., Ho, L. L., Lee, C. H., Chang, Y. L.: (2006b)Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway. Br. J Pharmacol 148, 587–598
Claes, S. J.: (2004)Corticotropin-releasing hormone (CRH) in psychiatry: from stress to psychopathology. Ann Med 36, 50–61
Crochemore, C., Lu, J., Wu, Y., Liposits, Z., Sousa, N., Holsboer, F., Almeida, O. F.: (2005)Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry 10, 790–798
Cryan, J. F., Holmes, A.: (2005)The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev Drug Discov. 4, 775–790
Cryan, J. F., Mombereau, C.: (2004)In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9, 326–357
Cryan, J. F., Slattery, D. A.: (2007)Animal models of mood disorders: Recent developments. Curr. Opin. Psychiatry 20, 1–7
Cryan, J. F., Mombereau, C., Vassout, A.: (2005a)The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav. Rev 29, 571–625
Cryan, J. F., Valentino, R. J., Lucki, I.: (2005b)Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav. Rev 29, 547–569
Czesak, M., Lemonde, S., Peterson, E. A., Rogaeva, A., Albert, P. R.: (2006)Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J Neurosci 26, 1864–1871
David, D. J., Klemenhagen, K. C., Holick, K. A., Saxe, M. D., Mendez, I., Santarelli, L., Craig, D. A., Zhong, H., Swanson, C. J., Hegde, L. G., Ping, X. I., Dong, D., Marzabadi, M. R., Gerald, C. P., Hen, R.: (2007)Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphen yl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J Pharmacol Exp Ther 321, 237–248
Davidson, R. J., Irwin, W., Anderle, M. J., Kalin, N. H.: (2003)The neural substrates of affective processing in depressed patients treated with venlafaxine. Am. J. Psychiatry 160, 64–75
Pablo, J. M., De Parra, A., Segovia, S., Guillamon, A.: (1989)Learned immobility explains the behavior of rats in the forced swimming test. Physiol Behav 46, 229–237
Detke, M. J., Rickels, M., Lucki, I.: (1995)Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology. (Berl.) 121, 66–72
Dettling, M., Buhlmann, P.: (2004)Finding predictive gene groups from microarray data. J. Multivariate Analysis 90, 106–131
Draper, I., Kurshan, P. T., McBride, E., Jackson, F. R., Kopin, A. S.: (2007)Locomotor activity is regulated by D2-like receptors in Drosophila: an anatomic and functional analysis. Dev Neurobiol 67, 378–393
D’Sa, C., Duman, R. S.: (2002)Antidepressants and neuroplasticity. Bipolar Disord. 4, 183–194
Duncan, G. E., Breese, G. R., Criswell, H. E., Johnson, K. B., Schambra, U. B., Mueller, R. A., Caron, M. G., Fremeau, R. T., Jr. (1993)D1 dopamine receptor binding and mRNA levels are not altered after neonatal 6-hydroxydopamine treatment: evidence against dopamine-mediated induction of D1 dopamine receptors during postnatal development. J Neurochem 61, 1255–1262
Ehret, A., Birthelmer, A., Rutz, S., Riegert, C., Rothmaier, A. K., Jackisch, R.: (2007)Agonist-mediated regulation of presynaptic receptor function during development of rat septal neurons in culture. J Neurochem 102, 1071–1082
Emanuel, R. L., Girard, D. M., Thull, D. L., Majzoub, J. A.: (1990)Second messengers involved in the regulation of corticotropin-releasing hormone mRNA and peptide in cultured rat fetal hypothalamic primary cultures. Endocrinology 126, 3016–3021
Eriksson, P. S., Perfilieva, E., Bjork-Eriksson, T., Alborn, A. M., Nordborg, C., Peterson, D. A., Gage, F. H.: (1998)Neurogenesis in the adult human hippocampus. Nat. Med 4, 1313–1317
Evans, S. J., Choudary, P. V., Neal, C. R., Li, J. Z., Vawter, M. P., Tomita, H., Lopez, J. F., Thompson, R. C., Meng, F., Stead, J. D., Walsh, D. M., Myers, R. M., Bunney, W. E., Watson, S. J., Jones, E. G., Akil, H.: (2004)Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A 101, 15506–15511
Feezor, R. J., Baker, H. V., Mindrinos, M., Hayden, D., Tannahill, C. L., Brownstein, B. H., Fay, A., MacMillan, S., Laramie, J., Xiao, W., Moldawer, L. L., Cobb, J. P., Laudanski, K., Miller-Graziano, C. L., Maier, R. V., Schoenfeld, D., Davis, R. W., Tompkins, R. G.: (2004)Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 19, 247–254
Frank, R., Hargreaves, R.: (2003)Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov. 2, 566–580
Frenois, F., Cador, M., Caille, S., Stinus, L., Le, M. C.: (2002)Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16, 1377–1389
Frodl, T., Meisenzahl, E. M., Zetzsche, T., Hohne, T., Banac, S., Schorr, C., Jager, M., Leinsinger, G., Bottlender, R., Reiser, M., Moller, H. J.: (2004)Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J. Clin. Psychiatry 65, 492–499
Frohna, P. A., Neal-Beliveau, B. S., Joyce, J. N.: (1995)Neonatal 6-hydroxydopamine lesions lead to opposing changes in the levels of dopamine receptors and their messenger RNAs. Neuroscience 68, 505–518
Fu, C. H., Williams, S. C., Cleare, A. J., Brammer, M. J., Walsh, N. D., Kim, J., Andrew, C. M., Pich, E. M., Williams, P. M., Reed, L. J., Mitterschiffthaler, M. T., Suckling, J., Bullmore, E. T.: (2004)Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiatry 61, 877–889
Funada, M., Hara, C., Wada, K.: (2001)Involvement of corticotropin-releasing factor receptor subtype 1 in morphine withdrawal regulation of the brain noradrenergic system. Eur J Pharmacol 430, 277–281
Ganguly, S., Coon, S. L., Klein, D. C.: (2002)Control of melatonin synthesis in the mammalian pineal gland: the critical role of serotonin acetylation. Cell Tissue Res 309, 127–137
Garcia-Sevilla, J. A., Zis, A. P., Hollingsworth, P. J., Greden, J. F., Smith, C. B.: (1981)Platelet alpha 2-adrenergic receptors in major depressive disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment. Arch. Gen. Psychiatry 38, 1327–1333
Georges, M., Coppieters, W., Charlier, C.: (2007)Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Curr. Opin. Genet. Dev. 17, 166–176
Ghaffar, O., Feinstein, A.: (2007)The neuropsychiatry of multiple sclerosis: a review of recent developments. Curr. Opin. Psychiatry 20, 278–285
Gilbertson, M. W., Shenton, M. E., Ciszewski, A., Kasai, K., Lasko, N. B., Orr, S. P., Pitman, R. K.: (2002)Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat. Neurosci. 5, 1242–1247
Gladkevich, A., Kauffman, H. F., Korf, J.: (2004)Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog. Neuropsychopharmacol. Biol Psychiatry 28, 559–576
Glantz, L. A., Lewis, D. A.: (1997)Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch. Gen. Psychiatry 54, 943–952
Glavin, G. B.: (1985a)Selective noradrenaline depletion markedly alters stress responses in rats. Life Sci 37, 461–465
Glavin, G. B.: (1985b)Selective noradrenaline depletion markedly alters stress responses in rats. Life Sci 37, 461–465
Glavin, G. B.: (1985c)Stress and brain noradrenaline: a review. Neurosci Biobehav. Rev 9, 233–243
Gold, P. W., Charney, D. S.: (2002)Diseases of the mind and brain: depression: a disease of the mind, brain, and body. Am. J. Psychiatry 159, 1826
Gold, P. W., Chrousos, G. P.: (2002)Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 7, 254–275
Gross, C. G.: (2000)Neurogenesis in the adult brain: death of a dogma. Nat. Rev Neurosci 1, 67–73
Gur, R. E., Keshavan, M. S., Lawrie, S. M.: (2007)Deconstructing psychosis with human brain imaging. Schizophr. Bull. 33, 921–931
Halim, N. D., Weickert, C. S., McClintock, B. W., Weinberger, D. R., Lipska, B. K.: (2004)Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus. Neuropsychopharmacology 29, 1063–1069
Harrison, P. J., Weinberger, D. R.: (2005)Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10, 40–68
Heesen, C., Nawrath, L., Reich, C., Bauer, N., Schulz, K. H., Gold, S. M.: (2006)Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? J. Neurol. Neurosurg. Psychiatry 77, 34–39
Heim, C., Newport, D. J., Heit, S., Graham, Y. P., Wilcox, M., Bonsall, R., Miller, A. H., Nemeroff, C. B.: (2000)Pituitary–adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 284, 592–597
Heim, C., Plotsky, P. M., Nemeroff, C. B.: (2004)Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology 29, 641–648
Hillhouse, E. W., Milton, N. G.: (1989)Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro. J Endocrinol. 122, 713–718
Holmes, P. V.: (2003)Rodent models of depression: reexamining validity without anthropomorphic inference. Crit. Rev Neurobiol 15, 143–174
Holsboer, F.: (1999)The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J. Psychiatr. Res. 33, 181–214
Huang, Y. Y., Peng, C. H., Yang, Y. P., Wu, C. C., Hsu, W. M., Wang, H. J., Chan, K. H., Chou, Y. P., Chen, S. J., Chang, Y. L.: (2007)Desipramine activated Bcl-2 expression and inhibited lipopolysaccharide-induced apoptosis in hippocampus-derived adult neural stem cells. J Pharmacol Sci 104, 61–72
Huggett, J., Dheda, K., Bustin, S., Zumla, A.: (2005)Real-time RT-PCR normalisation; strategies and considerations. Genes Immun. 6, 279–284
Husum, H., Mikkelsen, J. D., Hogg, S., Mathe, A. A., Mork, A.: (2000)Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram. Neuropharmacology 39, 1463–1473
Iga, J., Ueno, S., Yamauchi, K., Motoki, I., Tayoshi, S., Ohta, K., Song, H., Morita, K., Rokutan, K., Ohmori, T.: (2005)Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine. Neurosci Lett. 389, 12–16
Iga, J., Ueno, S., Yamauchi, K., Numata, S., Motoki, I., Tayoshi, S., Kinouchi, S., Ohta, K., Song, H., Morita, K., Rokutan, K., Tanabe, H., Sano, A., Ohmori, T.: (2006)Gene expression and association analysis of LIM (PDLIM5) in major depression. Neurosci Lett. 400, 203–207
Iga, J., Ueno, S., Yamauchi, K., Numata, S., Kinouchi, S., Tayoshi-Shibuya, S., Song, H., Ohmori, T.: (2007a)Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 628–632
Iga, J., Ueno, S., Yamauchi, K., Numata, S., Tayoshi-Shibuya, S., Kinouchi, S., Nakataki, M., Song, H., Hokoishi, K., Tanabe, H., Sano, A., Ohmori, T.: (2007b)Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 658–663
Insel, T. R., Scolnick, E. M.: (2006)Cure therapeutics and strategic prevention: raising the bar for mental health research. Mol. Psychiatry 11, 11–17
Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Kunzel, H. E., Pfennig, A., Uhr, M., Holsboer, F.: (2007)Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker? Biol. Psychiatry 62, 47–54
Jarvinen, A. K., Hautaniemi, S., Edgren, H., Auvinen, P., Saarela, J., Kallioniemi, O. P., Monni, O.: (2004)Are data from different gene expression microarray platforms comparable? Genomics 83, 1164–1168
Jin, P., Zhao, Y., Ngalame, Y., Panelli, M. C., Nagorsen, D., Monsurro, V., Smith, K., Hu, N., Su, H., Taylor, P. R., Marincola, F. M., Wang, E.: (2004)Selection and validation of endogenous reference genes using a high throughput approach. BMC Genomics 5, 55
Kaddurah-Daouk, R., McEvoy, J., Baillie, R. A., Lee, D., Yao, J. K., Doraiswamy, P. M., Krishnan, K. R.: Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol. Psychiatry 1–12 (2007)
Kalman, J., Palotas, A., Juhasz, A., Rimanoczy, A., Hugyecz, M., Kovacs, Z., Galsi, G., Szabo, Z., Pakaski, M., Feher, L. Z., Janka, Z., Puskas, L. G.: (2005)Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression--evolution of antidepressants and the role of the “neuro-immune” system. Neurochem Res 30, 1429–1438
Karson, C. N., Mrak, R. E., Schluterman, K. O., Sturner, W. Q., Sheng, J. G., Griffin, W. S.: (1999)Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for ‘hypofrontality’. Mol Psychiatry 4, 39–45
Kasckow, J. W., Regmi, A., Sheriff, S., Mulchahey, J., Geracioti, T. D., Jr.: (1999)Regulation of corticotropin-releasing factor messenger RNA by nicotine in an immortalized amygdalar cell line. Life Sci 65, 2709–2714
Kasckow, J. W., Aguilera, G., Mulchahey, J. J., Sheriff, S., Herman, J. P.: (2003)In vitro regulation of corticotropin-releasing hormone. Life Sci 73, 769–781
Keck, M. E., Wigger, A., Welt, T., Muller, M. B., Gesing, A., Reul, J. M., Holsboer, F., Landgraf, R., Neumann, I. D.: (2002)Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 26, 94–105
Keck, M. E., Welt, T., Muller, M. B., Uhr, M., Ohl, F., Wigger, A., Toschi, N., Holsboer, F., Landgraf, R.: (2003)Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology 28, 235–243
Khan, A., Schwartz, K., Kolts, R. L., Ridgway, D., Lineberry, C.: (2007)Relationship between depression severity entry criteria and antidepressant clinical trial outcomes. Biol. Psychiatry 62, 65–71
Kitayama, N., Vaccarino, V., Kutner, M., Weiss, P., Bremner, J. D.: (2005)Magnetic resonance imaging (MRI) measurement of hippocampal volume in posttraumatic stress disorder: a meta-analysis. J. Affect. Disord. 88, 79–86
Kodama, M., Fujioka, T., Duman, R. S.: (2004)Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat. Biol Psychiatry 56, 570–580
Koldzic-Zivanovic, N., Seitz, P. K., Cunningham, K. A., Thomas, M. L., Hughes, T. K.: (2006)Serotonin regulation of serotonin uptake in RN46A cells. Cell Mol Neurobiol 26, 979–987
Konradi, C.: (2005)Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Brain Res Brain Res Rev 50, 142–155
Koob, G. F.: (1999)Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 46, 1167–1180
Kromer, S. A., Kessler, M. S., Milfay, D., Birg, I. N., Bunck, M., Czibere, L., Panhuysen, M., Putz, B., Deussing, J. M., Holsboer, F., Landgraf, R., Turck, C. W.: (2005a)Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 25, 4375–4384
Kromer, S. A., Kessler, M. S., Milfay, D., Birg, I. N., Bunck, M., Czibere, L., Panhuysen, M., Putz, B., Deussing, J. M., Holsboer, F., Landgraf, R., Turck, C. W.: (2005b)Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 25, 4375–4384
Kunzel, H. E., Binder, E. B., Nickel, T., Ising, M., Fuchs, B., Majer, M., Pfennig, A., Ernst, G., Kern, N., Schmid, D. A., Uhr, M., Holsboer, F., Modell, S.: (2003)Pharmacological and nonpharmacological factors influencing hypothalamic–pituitary–adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28, 2169–2178
Kupfer, D. J.: (1976)REM latency: a psychobiologic marker for primary depressive disease. Biol. Psychiatry 11, 159–174
Kupfer, D. J.: (1995)Sleep research in depressive illness: clinical implications--a tasting menu. Biol. Psychiatry 38, 391–403
Kupfer, D. J., Targ, E., Stack, J.: (1982)Electroencephalographic sleep in unipolar depressive subtypes: support for a biological and familial classification. J. Nerv. Ment. Dis. 170, 494–498
Kupfer, D. J., Reynolds, C. F., III, Grochocinski, V. J., Ulrich, R. F., McEachran, A.: (1986)Aspects of short REM latency in affective states: a revisit. Psychiatry Res. 17, 49–59
Kushwaha, N., Albert, P. R.: (2005)Coupling of 5-HT1A autoreceptors to inhibition of mitogen-activated protein kinase activation via G beta gamma subunit signaling. Eur J Neurosci 21, 721–732
Landgraf, R., Wigger, A.: (2002)High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety. Behav. Genet. 32, 301–314
Landgraf, R., Wigger, A., Holsboer, F., Neumann, I. D.: (1999)Hyper-reactive hypothalamo-pituitary–adrenocortical axis in rats bred for high anxiety-related behaviour. J. Neuroendocrinol. 11, 405–407
Lauer, C. J., Riemann, D., Wiegand, M., Berger, M.: (1991)From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biol. Psychiatry 29, 979–993
Lehrmann, E., Hyde, T. M., Vawter, M. P., Becker, K. G., Kleinman, J. E., Freed, W. J.: (2003)The use of microarrays to characterize neuropsychiatric disorders: postmortem studies of substance abuse and schizophrenia. Curr. Mol Med 3, 437–446
Leonard, B. E.: (2005)The HPA and immune axes in stress: the involvement of the serotonergic system. Eur. Psychiatry 20 Suppl 3, S302–S306
Leonard, B. E.: Inflammation, Depression and Dementia: Are they Connected? Neurochem. Res. (2007)
Liebsch, G., Linthorst, A. C., Neumann, I. D., Reul, J. M., Holsboer, F., Landgraf, R.: (1998a)Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior. Neuropsychopharmacology 19, 381–396
Liebsch, G., Montkowski, A., Holsboer, F., Landgraf, R.: (1998b)Behavioural profiles of two Wistar rat lines selectively bred for high or low anxiety-related behaviour. Behav Brain Res 94, 301–310
Lima, L., Mata, S., Urbina, M.: (2005)Allelic isoforms and decrease in serotonin transporter mRNA in lymphocytes of patients with major depression. Neuroimmunomodulation. 12, 299–306
Lorrain, D. S., Baccei, C. S., Correa, L. D., Bristow, L. J.: (2005)Comparison of the effects of diazepam, the CRF1 antagonist CP-154,526 and the group II mGlu receptor agonist LY379268 on stress-evoked extracellular norepinephrine levels. Neuropharmacology 48, 927–935
Lucki, I.: (1997)The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8, 523–532
Luo, Z., Geschwind, D. H.: (2001)Microarray applications in neuroscience. Neurobiol Dis 8, 183–193
Lyketsos, C. G., Olin, J.: (2002)Depression in Alzheimer’s disease: overview and treatment. Biol. Psychiatry 52, 243–252
Macmaster, F. P., Mirza, Y., Szeszko, P. R., Kmiecik, L. E., Easter, P. C., Taormina, S. P., Lynch, M., Rose, M., Moore, G. J., Rosenberg, D. R.: Amygdala and Hippocampal Volumes in Familial Early Onset Major Depressive Disorder. Biol. Psychiatry (2007)
Maier, W., Zobel, A., Wagner, M.: (2006)Schizophrenia and bipolar disorder: differences and overlaps. Curr. Opin. Psychiatry 19, 165–170
Maino, K., Gruber, R., Riedel, M., Seitz, N., Schwarz, M., Muller, N.: (2007)T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Psychiatry Res. 152, 173–180
Malberg, J. E., Duman, R. S.: (2003)Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28, 1562–1571
Marcotte, E. R., Srivastava, L. K., Quirion, R.: (2003)cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer’s disease. Pharmacol Ther 100, 63–74
Marsteller, D. A., Barbarich-Marsteller, N. C., Patel, V. D., Dewey, S. L.: (2007)Brain metabolic changes following 4-week citalopram infusion: Increased (18)FDG uptake and gamma-amino butyric acid levels. Synapse 61, 877–881
McDonald, C., Zanelli, J., Rabe-Hesketh, S., Ellison-Wright, I., Sham, P., Kalidindi, S., Murray, R. M., Kennedy, N.: (2004)Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol. Psychiatry 56, 411–417
McEwen, B. S.: (2001)Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann N Y Acad Sci 933, 265–277
Middleton, F. A., Mirnics, K., Pierri, J. N., Lewis, D. A., Levitt, P.: (2002)Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22, 2718–2729
Milak, M. S., Parsey, R. V., Keilp, J., Oquendo, M. A., Malone, K. M., Mann, J. J.: (2005)Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch. Gen. Psychiatry 62, 397–408
Millan, M. J.: (2003)The neurobiology and control of anxious states. Prog. Neurobiol 70, 83–244
Millan, M. J.: (2004)The role of monoamines in the actions of established and “novel” antidepressant agents: a critical review. Eur J Pharmacol 500, 371–384
Millan, M. J., Gobert, A., Bervoets, K., Rivet, J. M., Veiga, S., Brocco, M.: (2000)Induction of spontaneous tail-flicks in rats by blockade of transmission at N-methyl-D-aspartate receptors: roles of multiple monoaminergic receptors in relation to the actions of antipsychotic agents. J Pharmacol Exp Ther 292, 672–683
Mir, K. U.: (2006)Ultrasensitive RNA profiling: counting single molecules on microarrays. Genome. Res 16, 1195–1197
Mirnics, K., Pevsner, J.: (2004)Progress in the use of microarray technology to study the neurobiology of disease. Nat. Neurosci 7, 434–439
Mirnics, K., Levitt, P., Lewis, D. A.: (2006)Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry 60, 163–176
Molina, V. A., Heyser, C. J., Spear, L. P.: (1994)Chronic variable stress enhances the stimulatory action of a low dose of morphine: reversal by desipramine. Eur J Pharmacol 260, 57–64
Morey, J. S., Ryan, J. C., Dolah, F. M.: Van (2006)Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced. Online. 8, 175–193
Mortensen, O. V., Thomassen, M., Larsen, M. B., Whittemore, S. R., Wiborg, O.: (1999)Functional analysis of a novel human serotonin transporter gene promoter in immortalized raphe cells. Brain Res Mol Brain Res 68, 141–148
Mulchahey, J. J., Regmi, A., Sheriff, S., Balasubramaniam, A., Kasckow, J. W.: (1999)Coordinate and divergent regulation of corticotropin-releasing factor (CRF) and CRF-binding protein expression in an immortalized amygdalar neuronal cell line. Endocrinology 140, 251–259
Nemeroff, C. B., Bremner, J. D., Foa, E. B., Mayberg, H. S., North, C. S., Stein, M. B.: (2006)Posttraumatic stress disorder: a state-of-the-science review. J. Psychiatr. Res. 40, 1–21
Nestler, E. J., Gould, E., Manji, H., Buncan, M., Duman, R. S., Greshenfeld, H. K., Hen, R., Koester, S., Lederhendler, I., Meaney, M., Robbins, T., Winsky, L., Zalcman, S.: (2002)Preclinical models: status of basic research in depression. Biol Psychiatry 52, 503–528
Newton, S. S., Collier, E. F., Hunsberger, J., Adams, D., Terwilliger, R., Selvanayagam, E., Duman, R. S.: (2003)Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci 23, 10841–10851
Newton, S. S., Duman, R. S.: (2007)Neurogenic actions of atypical antipsychotic drugs and therapeutic implications. CNS. Drugs 21, 715–725
Nofzinger, E. A., Price, J. C., Meltzer, C. C., Buysse, D. J., Villemagne, V. L., Miewald, J. M., Sembrat, R. C., Steppe, D. A., Kupfer, D. J.: (2000)Towards a neurobiology of dysfunctional arousal in depression: the relationship between beta EEG power and regional cerebral glucose metabolism during NREM sleep. Psychiatry Res. 98, 71–91
Ohmori, T., Morita, K., Saito, T., Ohta, M., Ueno, S., Rokutan, K.: (2005)Assessment of human stress and depression by DNA microarray analysis. J Med Invest. 52 Suppl, 266–271
Owen, M. J., Craddock, N., O’donovan, M. C.: (2005)Schizophrenia: genes at last? Trends Genet 21, 518–525
Paige, L. A., Mitchell, M. W., Krishnan, K. R., Kaddurah-Daouk, R., Steffens, D. C.: A preliminary metabolomic analysis of older adults with and without depression. Int. J. Geriatr. Psychiatry (2006)
Pariante, C. M., Dazzan, P., Danese, A., Morgan, K. D., Brudaglio, F., Morgan, C., Fearon, P., Orr, K., Hutchinson, G., Pantelis, C., Velakoulis, D., Jones, P. B., Leff, J., Murray, R. M.: (2005)Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 30, 1923–1931
Parker, G.: (2000)Classifying depression: should paradigms lost be regained? Am. J. Psychiatry 157, 1195–1203
Parker, G., Malhi, G., Mitchell, P., Wilhelm, K., Austin, M. P., Crawford, J., Hadzi-Pavlovic, D.: (2005)Progressing a spectrum model for defining non-melancholic depression. Acta Psychiatr. Scand. 111, 139–143
Patil, S. T., Zhang, L., Martenyi, F., Lowe, S. L., Jackson, K. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Y., Morozova, M. A., Mosolov, S. N., Neznanov, N. G., Reznik, A. M., Smulevich, A. B., Tochilov, V. A., Johnson, B. G., Monn, J. A., Schoepp, D. D.: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat. Med. (2007)
Peng, C. H., Chiou, S. H., Chen, S. J., Chou, Y. C., Ku, H. H., Cheng, C. K., Yen, C. J., Tsai, T. H., Chang, Y. L., Kao, C. L.: Neuroprotection by Imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neuropsychopharmacol. (2007)
Petit-Demouliere, B., Chenu, F., Bourin, M.: (2005)Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology. (Berl.) 177, 245–255
Phillips, M. L., Drevets, W. C., Rauch, S. L., Lane, R.: (2003)Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol. Psychiatry 54, 515–528
Porsolt, R. D., Le, P. M., Jalfre, M.: (1977)Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730–732
Porsolt, R. D., Chermat, R., Lenegre, A., Avril, I., Janvier, S., Steru, L.: (1987)Use of the automated tail suspension test for the primary screening of psychotropic agents. Arch. Int Pharmacodyn. Ther 288, 11–30
Posternak, M. A., Zimmerman, M.: (2002)Partial validation of the atypical features subtype of major depressive disorder. Arch. Gen. Psychiatry 59, 70–76
Pruessner, J. C., Champagne, F., Meaney, M. J., Dagher, A.: (2004)Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J. Neurosci. 24, 2825–2831
Quitkin, F. M., Stewart, J. W., McGrath, P. J., Tricamo, E., Rabkin, J. G., Ocepek-Welikson, K., Nunes, E., Harrison, W., Klein, D. F.: Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo. Br. J. Psychiatry Suppl 30–34 (1993)
Ramirez, B. M., Bostic, J. Q., Davies, D., Rush, A. J., Witte, B., Hendrickse, W., Barnett, V.: (2000)Methods to improve diagnostic accuracy in a community mental health setting. Am. J. Psychiatry 157, 1599–1605
Rasmussen, K., Beitner-Johnson, D. B., Krystal, J. H., Aghajanian, G. K., Nestler, E. J.: (1990)Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J Neurosci 10, 2308–2317
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., Kaye, J. A., Leszek, J., Miller, B. L., Minthon, L., Quinn, J. F., Rabinovici, G. D., Robinson, W. H., Sabbagh, M. N., So, Y. T., Sparks, D. L., Tabaton, M., Tinklenberg, J., Yesavage, J. A., Tibshirani, R., Wyss-Coray, T.: Classification and prediction of clinical Alzheimer’s diagnosis based on plasma signaling proteins. Nat. Med (2007)
Robert, J. J., Hoffmann, R. F., Emslie, G. J., Hughes, C., Rintelmann, J., Moore, J., Armitage, R.: (2006)Sex and age differences in sleep macroarchitecture in childhood and adolescent depression. Sleep 29, 351–358
Rocc, P., De, L. C., Eva, C., Marchiaro, L., Milani, A. M., Musso, R., Ravizza, L., Zanalda, E., Bogetto, F.: (2002)Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression. Prog. Neuropsychopharmacol. Biol Psychiatry 26, 1155–1160
Rokutan, K., Morita, K., Masuda, K., Tominaga, K., Shikishima, M., Teshima-Kondo, S., Omori, T., Sekiyama, A.: (2005a)Gene expression profiling in peripheral blood leukocytes as a new approach for assessment of human stress response. J Med Invest. 52, 137–144
Rokutan, K., Morita, K., Masuda, K., Tominaga, K., Shikishima, M., Teshima-Kondo, S., Omori, T., Sekiyama, A.: (2005b)Gene expression profiling in peripheral blood leukocytes as a new approach for assessment of human stress response. J Med Invest. 52, 137–144
Rozeboom, A. M., Akil, H., Seasholtz, A. F.: (2007)Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc Natl Acad Sci U S A 104, 4688–4693
Rush, A. J., Zimmerman, M., Wisniewski, S. R., Fava, M., Hollon, S. D., Warden, D., Biggs, M. M., Shores-Wilson, K., Shelton, R. C., Luther, J. F., Thomas, B., Trivedi, M. H.: (2005)Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features. J. Affect. Disord. 87, 43–55
Sahay, A., Hen, R.: (2007)Adult hippocampal neurogenesis in depression. Nat. Neurosci 10, 1110–1115
Salchner, P., Singewald, N.: (2002)Neuroanatomical substrates involved in the anxiogenic-like effect of acute fluoxetine treatment. Neuropharmacology 43, 1238–1248
Salchner, P., Sartori, S. B., Sinner, C., Wigger, A., Frank, E., Landgraf, R., Singewald, N.: (2006)Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior. Neuropharmacology 50, 1048–1058
Schena, M., Shalon, D., Davis, R. W., Brown, P. O.: (1995)Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467–470
Schena, M., Shalon, D., Heller, R., Chai, A., Brown, P. O., Davis, R. W.: (1996)Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A 93, 10614–10619
Scheuch, K., Lautenschlager, M., Grohmann, M., Stahlberg, S., Kirchheiner, J., Zill, P., Heinz, A., Walther, D. J., Priller, J.: Characterization of a Functional Promoter Polymorphism of the Human Tryptophan Hydroxylase 2 Gene in Serotonergic Raphe Neurons. Biol Psychiatry (2007)
Schmidt, H. D., Duman, R. S.: (2007)The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18, 391–418
Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M., Greenberg, M. E.: (2006)A brain-specific microRNA regulates dendritic spine development. Nature 439, 283–289
Schulteis, G., Yackey, M., Risbrough, V., Koob, G. F.: (1998)Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. Pharmacol Biochem Behav 60, 727–731
Searfoss, G. H., Ryan, T. P., Jolly, R. A.: (2005)The role of transcriptome analysis in pre-clinical toxicology. Curr. Mol Med 5, 53–64
Segman, R. H., Shefi, N., Goltser-Dubner, T., Friedman, N., Kaminski, N., Shalev, A. Y.: (2005)Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol. Psychiatry 10, 500–13, 425
Selemon, L. D., Goldman-Rakic, P. S.: (1999)The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 45, 17–25
Seligman, M. E., Weiss, J., Weinraub, M., Schulman, A.: (1980)Coping behavior: learned helplessness, physiological change and learned inactivity. Behav Res Ther 18, 459–512
Sheline, Y. I., Barch, D. M., Donnelly, J. M., Ollinger, J. M., Snyder, A. Z., Mintun, M. A.: (2001)Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry 50, 651–658
Shelton, R. C., Liang, S., Liang, P., Chakrabarti, A., Manier, D. H., Sulser, F.: (2004)Differential expression of pentraxin 3 in fibroblasts from patients with major depression. Neuropsychopharmacology 29, 126–132
Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de, L. F., Kawasaki, E. S., Lee, K. Y., Luo, Y., Sun, Y. A., Willey, J. C., Setterquist, R. A., Fischer, G. M., Tong, W., Dragan, Y. P., Dix, D. J., Frueh, F. W., Good-said, F. M., Herman, D., Jensen, R. V., Johnson, C. D., Loben-hofer, E. K., Puri, R. K., Schrf, U., Thierry-Mieg, J., Wang, C., Wilson, M., Wolber, P. K., Zhang, L., Amur, S., Bao, W., Bar-bacioru, C. C., Lucas, A. B., Bertholet, V., Boysen, C., Bromley, B., Brown, D., Brunner, A., Canales, R., Cao, X. M., Cebula, T. A., Chen, J. J., Cheng, J., Chu, T. M., Chudin, E., Corson, J., Corton, J. C., Croner, L. J., Davies, C., Davison, T. S., Delen-starr, G., Deng, X., Dorris, D., Eklund, A. C., Fan, X. H., Fang, H., Fulmer-Smentek, S., Fuscoe, J. C., Gallagher, K., Ge, W., Guo, L., Guo, X., Hager, J., Haje, P. K., Han, J., Han, T., Har-bottle, H. C., Harris, S. C., Hatchwell, E., Hauser, C. A., Hester, S., Hong, H., Hurban, P., Jackson, S. A., Ji, H., Knight, C. R., Kuo, W. P., LeClerc, J. E., Levy, S., Li, Q. Z., Liu, C., Liu, Y., Lombardi, M. J., Ma, Y., Magnuson, S. R., Maqsodi, B., McDaniel, T., Mei, N., Myklebost, O., Ning, B., Novora-dovskaya, N., Orr, M. S., Osborn, T. W., Papallo, A., Patterson, T. A., Perkins, R. G., Peters, E. H., Peterson, R., Philips, K. L., Pine, P. S., Pusztai, L., Qian, F., Ren, H., Rosen, M., Rosenzweig, B. A., Samaha, R. R., Schena, M., Schroth, G. P., Shchegrova, S., Smith, D. D., Staedtler, F., Su, Z., Sun, H., Szal-lasi, Z., Tezak, Z., Thierry-Mieg, D., Thompson, K. L., Tik-honova, I., Turpaz, Y., Vallanat, B., Van, C., Walker, S. J., Wang, S. J., Wang, Y., Wolfinger, R., Wong, A., Wu, J., Xiao, C., Xie, Q., Xu, J., Yang, W., Zhang, L., Zhong, S., Zong, Y., Slikker, W., Jr.: The MicroArray Quality Control (MAQC) pro-ject shows inter- and intraplatform reproducibility of gene ex-pression measurements. Nat. Biotechnol. 24, 1151-1161 (2006a)
Sibille, E., Arango, V., Galfalvy, H. C., Pavlidis, P., Erraji-Benchekroun, L., Ellis, S. P., John, M. J.: (2004)Gene expression profiling of depression and suicide in human prefrontal cortex. Neuropsychopharmacology 29, 351–361
Smagin, G. N., Harris, R. B., Ryan, D. H.: (1996)Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats. Neurosci Lett. 220, 167–170
Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., Zohar, J., Mendlewicz, J.: (2007)Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J. Clin. Psychiatry 68, 1062–1070
Sousa, N., Cerqueira, J. J., Almeida, O. F.: Corticosteroid receptors and neuroplasticity. Brain Res Rev (2007)
Stafford, P., Brun, M.: (2007)Three methods for optimization of cross-laboratory and cross-platform microarray expression data. Nucleic. Acids Res 35, e72
Stahl, S. M., Woo, D. J., Mefford, I. N., Berger, P. A., Ciaranello, R. D.: (1983)Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders. Am. J. Psychiatry 140, 26–30
Stewart, J. W., McGrath, P. J., Quitkin, F. M., Rabkin, J. G., Harrison, W., Wager, S., Nunes, E., Ocepek-Welikson, K., Tricamo, E.: (1993)Chronic depression: response to placebo, imipramine, and phenelzine. J. Clin. Psychopharmacol. 13, 391–396
Sullivan, P. F., Fan, C., Perou, C. M.: (2006)Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141, 261–268
Sun, W., Park, K. W., Choe, J., Rhyu, I. J., Kim, I. H., Park, S. K., Choi, B., Choi, S. H., Park, S. H., Kim, H.: (2005)Identification of novel electroconvulsive shock-induced and activity-dependent genes in the rat brain. Biochem Biophys. Res Commun. 327, 848–856
Suri, C., Fung, B. P., Tischler, A. S., Chikaraishi, D. M.: (1993)Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. J Neurosci 13, 1280–1291
Suzuki, Y., Sawamura, K., Someya, T.: (2006)Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients. Neuropsychopharmacology 31, 825–831
Swanson, C. J., Perry, K. W., Schoepp, D. D.: (2004)The mGlu2/3 receptor agonist, LY354740, blocks immobilization-induced increases in noradrenaline and dopamine release in the rat medial prefrontal cortex. J Neurochem 88, 194–202
Swanson, C. J., Blackburn, T. P., Zhang, X., Zheng, K., Xu, Z. Q., Hokfelt, T., Wolinsky, T. D., Konkel, M. J., Chen, H., Zhong, H., Walker, M. W., Craig, D. A., Gerald, C. P., Branchek, T. A.: (2005a)Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci U S A 102, 17489–17494
Swanson, C. J., Bures, M., Johnson, M. P., Linden, A. M., Monn, J. A., Schoepp, D. D.: (2005b)Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat. Rev Drug Discov. 4, 131–144
Tanna, V. L., Wilson, A. F., Winokur, G., Elston, R. C.: (1989)Linkage analysis of pure depressive disease. J Psychiatr. Res 23, 99–107
Tanner, M. A., Berk, L. S., Felten, D. L., Blidy, A. D., Bit, S. L., Ruff, D. W.: (2002)Substantial changes in gene expression level due to the storage temperature and storage duration of human whole blood. Clin Lab. Haematol. 24, 337–341
Taylor, D. J., Lichstein, K. L., Durrence, H. H., Reidel, B. W., Bush, A. J.: (2005)Epidemiology of insomnia, depression, and anxiety. Sleep 28, 1457–1464
Taylor, M. A., Fink, M.: Restoring melancholia in the classification of mood disorders. J. Affect. Disord. (2007)
Thiel, G., Cibelli, G.: (1999)Corticotropin-releasing factor and vasoactive intestinal polypeptide activate gene transcription through the cAMP signaling pathway in a catecholaminergic immortalized neuron. Neurochem Int 34, 183–191
Toro, C. T., Deakin, J. F.: (2007)Adult neurogenesis and schizophrenia: a window on abnormal early brain development? Schizophr. Res 90, 1–14
Tsao, C. W., Lin, Y. S., Chen, C. C., Bai, C. H., Wu, S. R.: (2006)Cytokines and serotonin transporter in patients with major depression. Prog. Neuropsychopharmacol. Biol Psychiatry 30, 899–905
Tsuang, M. T., Nossova, N., Yager, T., Tsuang, M. M., Guo, S. C., Shyu, K. G., Glatt, S. J., Liew, C. C.: (2005)Assessing the validity of blood-based gene expression profiles for the classification of schizophrenia and bipolar disorder: a preliminary report. Am. J Med Genet B Neuropsychiatr. Genet 133, 1–5
Ungerstedt, U.: (1971)Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand. Suppl. 367, 1–48
Vandergriff, J., Rasmussen, K.: (1999)The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropharmacology 38, 217–222
Vandesompele, J., De, P. K., Pattyn, F., Poppe, B., Van, R. N., De, P. A., Speleman, F.: Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome. Biol 3, RESEARCH0034 (2002)
Praag, H. M.: Van (1999)On what evidence should education concerning depression be based? Int Clin Psychopharmacol. 14 Suppl 3, S35–S39
Vawter, M. P., Ferran, E., Galke, B., Cooper, K., Bunney, W. E., Byerley, W.: (2004a)Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr. Res 67, 41–52
Vawter, M. P., Shannon, W. C., Ferran, E., Matsumoto, M., Overman, K., Hyde, T. M., Weinberger, D. R., Bunney, W. E., Kleinman, J. E.: (2004b)Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia. Neurochem Res 29, 1245–1255
Velculescu, V. E., Zhang, L., Vogelstein, B., Kinzler, K. W.: (1995)Serial analysis of gene expression. Science 270, 484–487
Vermetten, E., Vythilingam, M., Southwick, S. M., Charney, D. S., Bremner, J. D.: (2003)Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder. Biol. Psychiatry 54, 693–702
Vgontzas, A. N., Bixler, E. O., Chrousos, G. P.: (2006)Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann. N. Y. Acad. Sci. 1083, 329–344
Vogel, M., Pfeifer, S., Schaub, R. T., Grabe, H. J., Barnow, S., Freyberger, H. J., Cascorbi, I.: (2004)Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients. Neuropsychobiology 50, 305–310
Wagner, J. A., Williams, S. A., Webster, C. J.: (2007)Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs. Clin. Pharmacol. Ther. 81, 104–107
Walker, E. F., Walder, D. J., Reynolds, F.: (2001)Developmental changes in cortisol secretion in normal and at-risk youth. Dev. Psychopathol. 13, 721–732
Walsh, B. T., Seidman, S. N., Sysko, R., Gould, M.: (2002)Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287, 1840–1847
Walsh, J. K., Deacon, S., Dijk, D. J., Lundahl, J.: (2007)The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia. Sleep 30, 593–602
Wang, H. D., Dunnavant, F. D., Jarman, T., Deutch, A. Y.: (2004)Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat. Neuropsychopharmacology 29, 1230–1238
Wang, Y., Barbacioru, C., Hyland, F., Xiao, W., Hunkapiller, K. L., Blake, J., Chan, F., Gonzalez, C., Zhang, L., Samaha, R. R.: (2006)Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics 7, 59
Warner-Schmidt, J. L., Duman, R. S.: (2007)VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A 104, 4647–4652
Weintraub, D., Stern, M. B.: (2005)Psychiatric complications in Parkinson disease. Am. J. Geriatr. Psychiatry 13, 844–851
West, A. P.: (1990)Neurobehavioral studies of forced swimming: the role of learning and memory in the forced swim test. Prog. Neuropsychopharmacol. Biol Psychiatry 14, 863–877
Wichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpe, S., Maes, M.: (2005)IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol. Psychiatry 10, 538–544
Willner, P.: (1997)Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology. (Berl.) 134, 319–329
Wong, D. L., Tank, A. W.: (2007)Stress-induced catecholaminergic function: transcriptional and post-transcriptional control. Stress 10, 121–130
Xu, J. F., Chen, X. Q., Du, J. Z., Wang, T. Y.: (2005)CRF receptor type 1 mediates continual hypoxia-induced CRF peptide and CRF mRNA expression increase in hypothalamic PVN of rats. Peptides. 26, 639–646
Zetzsche, T., Frodl, T., Preuss, U. W., Schmitt, G., Seifert, D., Leinsinger, G., Born, C., Reiser, M., Moller, H. J., Meisenzahl, E. M.: (2006)Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biol. Psychiatry 60, 302–310
Zhu, C. B., Blakely, R. D., Hewlett, W. A.: (2006)The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31, 2121–2131
Zieker, J., Zieker, D., Jatzko, A., Dietzsch, J., Nieselt, K., Schmitt, A., Bertsch, T., Fassbender, K., Spanagel, R., Northoff, H., Gebicke-Haerter, P. J.: (2007)Differential gene expression in peripheral blood of patients suffering from post-traumatic stress disorder. Mol Psychiatry 12, 116–118
Zimmerman, M., Chelminski, I., Posternak, M. A.: (2005)Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial. Am. J. Psychiatry 162, 1370–1372
Zusso, M., Debetto, P., Guidolin, D., Giusti, P.: (2004)Cerebellar granular cell cultures as an in vitro model for antidepressant drug-induced neurogenesis. Crit. Rev Neurobiol 16, 59–65
Acknowledgments
The authors thank Erik Mosekilde from the Technical University of Denmark for his contribution to the exploratory statistical analyses of the transcription data generated by Lundbeck Research USA. The work done by Erik Mosekilde and Wiktor Mazin was supported by the European Union through the Network of Excellence BioSim, Contract No. LSHB-CT-2004-005137.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Antonijevic, I. et al. (2008). Perspectives for an Integrated Biomarker Approach to Drug Discovery and Development. In: Turck, C. (eds) Biomarkers for Psychiatric Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-79251-4_15
Download citation
DOI: https://doi.org/10.1007/978-0-387-79251-4_15
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-79250-7
Online ISBN: 978-0-387-79251-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)